Sort   by:  
 Page size 
GenomicsKIR2DS2 B cells
KIR2DS2 expression identifies NK cells with enhanced anti-cancer activity
PRJEB49119 | ENA
UnknownKIR2DS2 Expression Identifies NK Cells With Enhanced Anticancer Activity.
Not available
S-EPMC7613074 | biostudies-literature
UnknownKIR2DS2+ NK cells in cancer patients demonstrate high activation in response to tumour-targeting antibodies.
Not available
S-EPMC11402612 | biostudies-literature
UnknownKIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT).
Not available
S-EPMC3478408 | biostudies-literature
UnknownNK cells with KIR2DS2 immunogenotype have a functional activation advantage to efficiently kill glioblastoma and prolong animal survival.
Not available
S-EPMC4259203 | biostudies-literature
UnknownExpression of activating KIR2DS2 and KIR2DS4 genes after hematopoietic cell transplantation: relevance to cytomegalovirus infection.
Not available
S-EPMC3199314 | biostudies-literature
UnknownCrystal structure of the human natural killer cell activating receptor KIR2DS2 (CD158j).
Not available
S-EPMC2193886 | biostudies-literature
UnknownDiverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3.
Not available
S-EPMC3504360 | biostudies-literature
ProteomicsThe nuclear export protein XPO1 provides a peptide ligand for natural killer cells
XPO1 is a nuclear export protein that is frequently overexpressed in cancer and functions as a driver of oncogenesis. Currently small molecules that target XPO1 are being used in the clinic as anti-cancer agents. We identify XPO1 as a target for natural killer (NK) cells. Using immunopeptidomics w...
ORGANISM(S): Homo sapiens (Human) 
2024-10-17 | PXD053264 | Pride
Natural killer cells Kir2ds2 Hla-c*0102 Huh7 cells Hepatocellular carcinoma 
UnknownActivating killer cell immunoglobulin-like receptor 2DS2 binds to HLA-A*11.
Not available
S-EPMC3932910 | biostudies-literature
Sort   by:  
 Page size